STRV | USCA | STRV / USCA | |
Gain YTD | 14.576 | 11.682 | 125% |
Net Assets | 1.03B | 3.2B | 32% |
Total Expense Ratio | 0.05 | 0.07 | 71% |
Turnover | 4.00 | 20.00 | 20% |
Yield | 1.07 | 1.18 | 91% |
Fund Existence | 3 years | 2 years | - |
STRV | USCA | |
---|---|---|
RSI ODDS (%) | 2 days ago64% | 2 days ago52% |
Stochastic ODDS (%) | 2 days ago73% | 2 days ago58% |
Momentum ODDS (%) | 2 days ago87% | 2 days ago80% |
MACD ODDS (%) | 2 days ago90% | 2 days ago78% |
TrendWeek ODDS (%) | 2 days ago88% | 2 days ago86% |
TrendMonth ODDS (%) | 2 days ago87% | 2 days ago85% |
Advances ODDS (%) | 3 days ago87% | 9 days ago87% |
Declines ODDS (%) | 23 days ago69% | 23 days ago58% |
BollingerBands ODDS (%) | 2 days ago63% | 2 days ago55% |
Aroon ODDS (%) | 2 days ago85% | 2 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XFLT | 5.39 | 0.04 | +0.75% |
XAI Octagon Floating Rate and Alternative Income Trust | |||
BLUBF | 5.55 | N/A | N/A |
Blue Ribbon Income Fund | |||
JHPI | 23.37 | -0.02 | -0.09% |
JHancock Preferred Income ETF | |||
FTXH | 28.09 | -0.05 | -0.19% |
First Trust Nasdaq Pharmaceuticals ETF | |||
IMCG | 82.51 | -0.35 | -0.42% |
iShares Morningstar Mid-Cap Growth ETF |
A.I.dvisor indicates that over the last year, USCA has been closely correlated with EMR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if USCA jumps, then EMR could also see price increases.
Ticker / NAME | Correlation To USCA | 1D Price Change % | ||
---|---|---|---|---|
USCA | 100% | -0.54% | ||
EMR - USCA | 73% Closely correlated | -1.04% | ||
AXP - USCA | 73% Closely correlated | +0.14% | ||
CG - USCA | 70% Closely correlated | -0.87% | ||
FTV - USCA | 69% Closely correlated | +0.25% | ||
C - USCA | 68% Closely correlated | -0.47% | ||
More |